medigraphic.com
ISSN 2520-9078 (Electronic)

2020, Number 3

<< Back Next >>

Revista de Ciencias Médicas de la Habana 2020; 27 (3)

COVID-19: jottings from an integrative revision

Hernández PR, Aguilar HI, Hernández NA, Hernández SY, Lemus LE

Language: Spanish
References: 30
Page: 369-410
PDF size: 810.58 Kb.


ABSTRACT

Introduction: Due to the increasing morbidity by COVID-19, the health professionals demand bibliographical revisions which determine its epidemiological characteristics.
Objective: To deep in the current scientific evidences about COVID-19.
Methods: An integrator revision in four data bases PubMed, SciELO, Dialnet Plus and Cochrane Plus was performed in March, 2020. Descriptors for Boolean operator AND and OR were used. The inclusion criteria were: articles with free access published in Spanish, English or Portuguese and duplicated and low methodological quality studies were excluded, which were evaluated by a critical reading.
Conclusions: The results showed that there is no vaccine or effective medication to stop the accelerated development of SARS-CoV-2. The first efforts have been centered in describing the clinical course, to count the critical cases and to treat ill individuals, to relieve the symptoms and support vital functions.


REFERENCES

  1. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries [Internet]. 2020 [citado 23 Mar 2020];14(2):125-28. Disponible en: https://jidc.org/index.php/journal/article/view/32146445https://doi.org/10.3855/jidc.12600

  2. Serra Valdés MA. Infección respiratoria aguda por COVID-19: una amenaza evidente. Rev Haban Cienc Méd [Internet]. 2020 Feb [citado 20 Jul 2020];19(1):1-5. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000100001&lng=es

  3. Ko WC, Rolain JM, Lee NY. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. International Journal of Antimicrobial Agents [Internet]. 2020 [citado 31 Mar 2020];55(4). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135364/

  4. Ena J, Wenzel RP. Un nuevo coronavirus emerge. Rev Clin Esp [Internet]. 2020 [citado 23 Abr 2020];220(2):115-6. Disponible en: https://www.revclinesp.es/es-un-nuevo-coronavirus-emerge-articulo-S0014256520300217

  5. Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology [Internet]. 2020 Jan [citado 23 Mar 2020];92(4) Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26048

  6. World Health Organization. [Internet]. Washington, DC: World Health Organization; 2020 [citado 12 Abr 2020]. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Disponible en: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf

  7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med [Internet]. 2020 Feb [citado 4 Mar 2020];382:727-33. Disponible en: https://www.nejm.org/doi/10.1056/NEJMoa2001017?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov http://doi.org/10.1056/NEJMoa2001017

  8. Paules CI, Marston HD, Fauci AS. Coronavirus Infections- More Than Just the Common Cold. JAMA [Internet]. 2020 [citado 30 Ene 2020];323(8):707-8. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2759815

  9. World Health Organization. [Internet]. Washington, DC: World Health Organization; 2020 [citado 2020 Abr 22]. Coronavirus disease 2019 (COVID-19), Situation Report- 93. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200422-sitrep-93-covid-19.pdf?sfvrsn=35cf80d7_4

  10. Infomed infecciones por coronavirus. [Internet]. La Habana: Centro Nacional de Información de Ciencias Médicas/INFOMED; ©2020 [citado 2020 Mar 24]. Actualización epidemiológica. Nuevo coronavirus (2019-nCoV). Disponible en: https://temas.sld.cu/coronavirus/2020/03/24/nuevo-coronavirus-2019-ncov-actualizacion

  11. Lipsitch M, Swerdlow DL, Finelli L. Defining the Epidemiology of Covid-19. Studies Needed. N Engl J Med [Internet]. 2020 Mar [citado 4 Mar 2020];382(13):1194-6. Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMp2002125?articleTools=true

  12. Chen N, Zhou M, Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020 [citado 28 Mar 2020];395(10223):507-13. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135076/

  13. Mohamed E, Josef D. From SARS to COVID-19: A previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans. One Health [Internet]. 2020 Feb [citado 4 Abr 2020];9(1). Disponible en: https://www.sciencedirect.com/science/article/pii/S2352771420300136?via%3Dihub

  14. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med [Internet]. 2020 Mar [citado 12 Abr 2020]; 172(9). Disponible en: https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported

  15. Jiong Wu, Xiaojia Wu, Wenbing Zeng, Dajing Guo, Zheng Fang, et al. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features. Investigative Radiology [Internet]. 2020 [citado 12 Abr 2020];55(5):257-61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147284/

  16. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020 Jan [citado 29 Mar 2020];395(10223):15-21. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620301835?via%3Dihub

  17. 17.Chung M, Bernheim A, Mei X. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology [Internet]. 2020 Feb [citado 2020 Mar 29]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194022/pdf/radiol.2020200230.pdf

  18. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress síndrome.. Lancet Respir Med [Internet]. 2020 Feb [citado 28 Mar 2020];8(4):420-22. Disponible en: https://www.sciencedirect.com/science/article/pii/S221326002030076X?via%3Dihub

  19. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet [Internet]. 2020 [citado 28 Mar 2020];395 (10226):809-15. Disponible en: https://www.sciencedirect.com/science/article/pii/S0140673620303603

  20. Li Q, Guan X, Wu P. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med [Internet]. 2020 [citado 25 Mar 2020]. 382(13):1199-207. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121484/

  21. Clark DR, Jonathan EM, JKB. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet [Internet]. 2020 [citado 28 Mar 2020];395(10223):473-5 Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134694/

  22. Chávez Eduardo T, Saavedra Leveau C, Ticona Huaroto C, Hidalgo García A. COVID-19: En este momento podría ser útil el tratamiento antiviral en casos leves. An Fac Med. [Internet]. 2020 Mar [citado 20 Jul 2020];81(1):87-91. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832020000100087&lng=es

  23. Gautret Ph, Lagier JC, Parola Ph, Thuan Hoang V, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents [Internet]. 2020 [citado 31 Mar 2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102549/pdf/main.pdf

  24. Nie J, Li Q, Wu J, Zhao CH, Hao H, Liu H, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerging Microbes & Infections [Internet]. 2020 [citado 29 Mar 2020];9(1):680-6. Disponible en: https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1743767

  25. Wu A, Peng Y, Huang B. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe [Internet]. 2020 [citado 29 Mar 2020];27(3):325-8. Disponible en: https://www.sciencedirect.com/science/article/pii/S193131282030072X?via%3Dihub

  26. Peña López BO, Rincón Orozco B. Generalidades de la pandemia por COVID-19 y su asociación genética con el virus del SARS. Salud UIS [Internet]. 2020 [citado 21 Mar 2020];52(2):83-6. Disponible en: https://revistas.uis.edu.co/index.php/revistasaluduis/article/view/10639/10446

  27. Song Z, Xu Y, Bao L. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses [Internet]. 2019 [citado 30 Ene 2020];11(59):11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357155/pdf/viruses-11-00059.pdf

  28. Pan F, Ye T, Sun P. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology [Internet]. 2020 Feb [citado 29 Mar 2020];295(3). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233367/

  29. Loras C, Sanz JC. Información preliminar de las características virológicas del nuevo coronavirus SARS-CoV-2. REMASP [Internet]. 2020 [citado 20 Jul 2020];4(2):1-10. Disponible en: http://remasp.es/article/view/1890

  30. Jiang F, Deng L, Zhang L, Cai Y, Wai Cheung C, Xia Z. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19). Journal of General Internal Medicine [Internet]. 2020 [citado 27 Mar 2020];35:545-9. Disponible en: https://link.springer.com/article/10.1007/s11606-020-05762-w




2020     |     www.medigraphic.com